'31 kda' presentation slideshows

31 kda - PowerPoint PPT Presentation


PLSCR1

PLSCR1

Figure S2. A. SnoN mRNA Levels. 1h IFN-2 α. Untreated. 3h IFN-2 α. C. B. HEY: IFN-2 α. HEY: IFN - 2α. Control siRNA. SnoN siRNA. 6h. 6h. IFN+NAC (1000). 0h. 0h. IFN+NAC (100). IFN+NAC (500). NAC (1000). IFN only. None. 38 kDa. PLSCR1. 31 kDa. 38 kDa. PLSCR1.

By marlee
(154 views)

PLSCR1

PLSCR1

Figure S2. A. SnoN mRNA Levels. 1h IFN-2 α. Untreated. 3h IFN-2 α. C. B. HEY: IFN-2 α. HEY: IFN - 2α. Control siRNA. SnoN siRNA. 6h. 6h. IFN+NAC (1000). 0h. 0h. IFN+NAC (100). IFN+NAC (500). NAC (1000). IFN only. None. 38 kDa. PLSCR1. 31 kDa. 38 kDa. PLSCR1.

By kiayada-webb
(80 views)


View 31 kda PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of 31 kda PowerPoint presentations. You can view or download 31 kda presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.

Related Searches for 31 kda
kDa

kDa

By haven (108 views)

kDa

kDa

p I. 3. 10. kDa. A genome. 150. 27. 25. 28. 26. 24. 100. 87. 20. 19. 85. 90. 18. 75.0. 86. 6. 2. 61. 1. 84. 88. 89. 22. 23. 21. 83. 7. 82. 3. 5. 50.0. 15. 4. 17. 13. 16. 14. 11. 29. 30. 81. 10. 62. 65. 8. 9. 12. 80. 66. 37.0. 55. 79. 31. 67.

By dale (93 views)

kDa

kDa

M p24. M. M. M. Anti-p24. Anti-HIS. anti-Ricin. M 1 2. kDa. kDa. kDa. 95. 95. 130. 72. 72. 95. 72. 55. 55. 55. 43. 36. 36. 28. 34. C. 28. B. 26. 17. p24. 6xHIS. 6xHIS. RTB. p24.

By plato-moore (113 views)

kDa

kDa

The mannobiose -forming exo-mannanase involved in a new mannan catabolic pathway in Bacteroides fragilis Susumu Ito et al. kDa. 50. 40. 30. 25. M. 1. 2. The mannobiose -forming exo-mannanase involved in a new mannan catabolic pathway in Bacteroides fragilis Susumu Ito et al.

By nasia (138 views)

kDa

kDa

A. B. 1. blue dextran. GST-SSB. Mpn SSB. Mpn H 10 -SSB. GST. kDa. M. 55. Relative concentration ( ■). OD 280 ( ♦). 0,5. 40. 35. cyt. C. Mpn SSB. 25. ova. BSA. 0. 15. 3. 4. 1. 2. 5. Eluted fraction (ml).

By emmanuel-kline (85 views)

kDa

kDa

A. B. Control. SSAT. SPDS. SPMS. siRNA. - + + - + + - + + - + +. Doxycycline. s i ODC. Control. - - + - - + - - + - - +. kDa. Doxorubicin. 58. kDa. 0 4 8 0 4 8. Doxorubicin (Hrs ):. DNp73β. 58. DNp73. 46.

By karmac (0 views)

kDa

kDa

62. 62. 62. 62. 62. 62. 62. 62. Std Wt  escF  espADB fliI. kDa. SN. α -FliC hDMEM. WCL. SN. α- FliC LB. WCL.

By manning (103 views)

kDa

kDa

20. 13. -. kDa. Sc. Cg. Ca. Pp. CaMat α , native 13 | 2.4 | 2.3 | 2.2 kDa. 39. 33. 30. 28. CA1873, native 6.4 | 2.4 | 1.2 | 13.6 | 15.6 kDa. 37. 29. 22. CA0365, native 5.6 | 3.2 | 1.4 | 3.1 | 1.5 | 3.1 | 2.8 kDa. 15. 8. CA2974, refolded 8 | 1.3 | 12.2 | 15.6 kDa. 21.

By aphrodite-griffin (84 views)

kDa

kDa

A. kDa. 97. 66. 45. STXs. 30. GST. 20. 2. 3. 4. 2. 3. 4. STX2 AND STX3 IMMUNOBLOT. STX2 anti-serum. STX3 anti-serum. STX-GST. B. STX2 AND STX3 IMMUNOBLOT. STX2 anti-serum. STX3 anti-serum. kDa. 97. 66. 45. 31. 20. 14. Lane. 1. 2. 3. 4.

By alexia (131 views)

kDa

kDa

Cells. Virions. A. 293/RGP NaB/PonA. 293/RGP NaB/PonA. 18-4s NaB/PonA. 18-4s NaB/PonA. NL4-3 HIV-1. NL4-3 HIV-1. 293/RGP. 293/RGP. 18-4s. 18-4s. kDa. kDa. p55. 46. 66. p55. p39. 46. p39. 30. p31. 30. p24. p24. 21. a -Gag. a -Gag. 293/RGP NaB/PonA. 18-4s NaB/PonA.

By dareh (151 views)